Release Date: 02/04/24 08:48 Summary: Appendix 5B Cash Flow Report Price Sensitive: Yes Download Document 224.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%